Type / Class
Equity / American Depositary Shares, each representing 1 Ordinary Shares
Shares outstanding
100M
Number of holders
56
Total 13F shares, excl. options
13.2M
Shares change
+74.6K
Total reported value, excl. options
$226M
Value change
+$2.24M
Number of buys
23
Number of sells
-27
Price
$17.12

Significant Holders of Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) as of Q4 2019

69 filings reported holding CLLS - Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares as of Q4 2019.
Cellectis S.A. - American Depositary Shares, each representing 1 Ordinary Shares (CLLS) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13.2M shares of 100M outstanding shares and own 13.17% of the company stock.
Largest 10 shareholders include FMR LLC (3.18M shares), ARK Investment Management LLC (1.34M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.28M shares), Nikko Asset Management Americas, Inc. (1.28M shares), Capital International Investors (1.02M shares), Capital World Investors (875K shares), MORGAN STANLEY (714K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (575K shares), CITADEL ADVISORS LLC (498K shares), and CREDIT SUISSE AG/ (465K shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.